vs
Side-by-side financial comparison of Better Home & Finance Holding Co (BETR) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Better Home & Finance Holding Co is the larger business by last-quarter revenue ($44.3M vs $28.1M, roughly 1.6× ARS Pharmaceuticals, Inc.). ARS Pharmaceuticals, Inc. runs the higher net margin — -147.1% vs -3349.0%, a 3201.9% gap on every dollar of revenue. On growth, Better Home & Finance Holding Co posted the faster year-over-year revenue change (77.4% vs -67.6%).
Bajaj Finance Limited (BFL) is an Indian deposit-taking non-banking financial company (NBFC-UL) headquartered in Pune. It has 110.64 million customers and holds assets under management worth ₹462,250 crore (US$55 billion), as of September 2025.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
BETR vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.3M | $28.1M |
| Net Profit | $-39.9M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | -3376.8% | -147.6% |
| Net Margin | -3349.0% | -147.1% |
| Revenue YoY | 77.4% | -67.6% |
| Net Profit YoY | 32.6% | -182.8% |
| EPS (diluted) | $-2.52 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.3M | $28.1M | ||
| Q3 25 | $43.9M | $32.5M | ||
| Q2 25 | $44.1M | $15.7M | ||
| Q1 25 | $32.6M | $8.0M | ||
| Q4 24 | $25.0M | $86.6M | ||
| Q3 24 | $29.0M | $2.1M | ||
| Q2 24 | $32.3M | $500.0K | ||
| Q1 24 | $22.3M | $0 |
| Q4 25 | $-39.9M | $-41.3M | ||
| Q3 25 | $-39.1M | $-51.2M | ||
| Q2 25 | $-36.3M | $-44.9M | ||
| Q1 25 | $-50.6M | $-33.9M | ||
| Q4 24 | $-59.2M | $49.9M | ||
| Q3 24 | $-54.2M | $-19.1M | ||
| Q2 24 | $-41.4M | $-12.5M | ||
| Q1 24 | $-51.5M | $-10.3M |
| Q4 25 | -3376.8% | -147.6% | ||
| Q3 25 | -88.9% | -163.7% | ||
| Q2 25 | -81.9% | -302.9% | ||
| Q1 25 | -154.9% | -466.3% | ||
| Q4 24 | -1428.3% | 54.5% | ||
| Q3 24 | -186.5% | -1051.6% | ||
| Q2 24 | -127.6% | -3068.0% | ||
| Q1 24 | -230.8% | — |
| Q4 25 | -3349.0% | -147.1% | ||
| Q3 25 | -89.2% | -157.4% | ||
| Q2 25 | -82.2% | -285.6% | ||
| Q1 25 | -155.3% | -425.7% | ||
| Q4 24 | -1437.5% | 57.7% | ||
| Q3 24 | -187.0% | -925.0% | ||
| Q2 24 | -128.2% | -2503.2% | ||
| Q1 24 | -231.4% | — |
| Q4 25 | $-2.52 | $-0.41 | ||
| Q3 25 | $-2.56 | $-0.52 | ||
| Q2 25 | $-2.39 | $-0.46 | ||
| Q1 25 | $-3.33 | $-0.35 | ||
| Q4 24 | $-3.92 | $0.52 | ||
| Q3 24 | $-3.58 | $-0.20 | ||
| Q2 24 | $-2.74 | $-0.13 | ||
| Q1 24 | $-3.41 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.4M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $37.2M | $114.3M |
| Total Assets | $1.5B | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.4M | $245.0M | ||
| Q3 25 | $205.8M | $288.2M | ||
| Q2 25 | $221.5M | $240.1M | ||
| Q1 25 | $228.0M | $275.7M | ||
| Q4 24 | $264.9M | $314.0M | ||
| Q3 24 | $262.1M | $204.6M | ||
| Q2 24 | $378.8M | $218.7M | ||
| Q1 24 | $482.6M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $37.2M | $114.3M | ||
| Q3 25 | $41.9M | $147.7M | ||
| Q2 25 | $76.6M | $192.3M | ||
| Q1 25 | $-102.1M | $229.0M | ||
| Q4 24 | $-58.2M | $256.8M | ||
| Q3 24 | $388.0K | $201.0M | ||
| Q2 24 | $44.9M | $215.2M | ||
| Q1 24 | $76.3M | $223.9M |
| Q4 25 | $1.5B | $327.7M | ||
| Q3 25 | $1.4B | $372.8M | ||
| Q2 25 | $1.2B | $313.5M | ||
| Q1 25 | $1.0B | $327.3M | ||
| Q4 24 | $913.1M | $351.2M | ||
| Q3 24 | $845.2M | $217.6M | ||
| Q2 24 | $957.9M | $222.0M | ||
| Q1 24 | $841.6M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.6M | $-43.5M |
| Free Cash FlowOCF − Capex | $-167.8M | — |
| FCF MarginFCF / Revenue | -378.6% | — |
| Capex IntensityCapex / Revenue | 2.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-277.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.6M | $-43.5M | ||
| Q3 25 | $4.2M | $-47.0M | ||
| Q2 25 | $-56.3M | $-39.6M | ||
| Q1 25 | $-57.2M | $-40.7M | ||
| Q4 24 | $-380.0M | $42.0M | ||
| Q3 24 | $-10.6M | $-14.5M | ||
| Q2 24 | $-220.6M | $-7.3M | ||
| Q1 24 | $-42.8M | $-6.7M |
| Q4 25 | $-167.8M | — | ||
| Q3 25 | $4.0M | $-47.2M | ||
| Q2 25 | $-56.7M | $-39.6M | ||
| Q1 25 | $-57.4M | $-40.8M | ||
| Q4 24 | $-383.4M | $41.7M | ||
| Q3 24 | $-11.7M | $-14.6M | ||
| Q2 24 | $-221.8M | $-7.3M | ||
| Q1 24 | $-43.3M | $-6.8M |
| Q4 25 | -378.6% | — | ||
| Q3 25 | 9.1% | -145.4% | ||
| Q2 25 | -128.5% | -252.2% | ||
| Q1 25 | -176.3% | -512.1% | ||
| Q4 24 | -1534.6% | 48.2% | ||
| Q3 24 | -40.5% | -706.3% | ||
| Q2 24 | -687.6% | -1463.4% | ||
| Q1 24 | -194.5% | — |
| Q4 25 | 2.7% | 0.0% | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.9% | 0.3% | ||
| Q1 25 | 0.6% | 1.1% | ||
| Q4 24 | 13.6% | 0.3% | ||
| Q3 24 | 4.1% | 6.8% | ||
| Q2 24 | 3.9% | 7.6% | ||
| Q1 24 | 2.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BETR
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
